Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy.
Ontology highlight
ABSTRACT: Boron neutron capture therapy (BNCT) is a binary cancer therapy that involves boron administration and neutron irradiation. The nuclear reaction caused by the interaction of boron atom and neutron produces heavy particles with highly cytocidal effects and destruct tumor cells, which uptake the boron drug. p-Boronophenylalanine (BPA), an amino acid derivative, is used in BNCT. Tumor cells with increased nutrient requirements take up more BPA than normal tissues via the enhanced expression of LAT1, an amino acid transporter. The current study aimed to assess the correlation between the expression of LAT1 and the uptake capacity of BPA using genetically modified LAT1-deficient/enhanced cell lines. We conducted an in vitro study, SCC7 tumor cells wherein LAT1 expression was altered using CRISP
SUBMITTER: Watanabe T
PROVIDER: S-EPMC9855323 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA